search
Back to results

Dexmedetomidine Versus Fentanyl for Sedation of Postoperative Mechanically Ventilated Neonates

Primary Purpose

Postoperative Pain

Status
Completed
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
Dexmedetomidine
Fentanyl
Sponsored by
Mansoura University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Postoperative Pain

Eligibility Criteria

1 Hour - 4 Weeks (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Neonates need postoperative ventilation.

Exclusion Criteria:

  1. Major congenital cardiovascular anomalies.
  2. Chromosomal anomalies.
  3. Grade IV intraventricular hemorrhage.
  4. Tracheoesophageal fistula with wide gap (distance between proximal and distal end more than two centimeters).

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    Fentanyl

    Dexmedetomidine

    Arm Description

    Neonates received fentanyl infusion during postoperative phase.

    Neonates received dexmedetomidine infusion during postoperative phase.

    Outcomes

    Primary Outcome Measures

    The efficacy of postoperative sedation according to pain score.
    Assessment of Neonatal Pain, Agitation and Sedation Scale immediately after the operations then every 12 hours till 5 days

    Secondary Outcome Measures

    Plasma cortisol level
    Plasma as a base line after the operation and another two measures one after 24 hours from the operation and the other after 48 hours
    Need of adjuvant analgesics or sedatives
    Infants in both groups received open-label intravenous fentanyl boluses at a dose of 1µg/kg, as adjuvant analgesic when the pain score was more than 3 points. The dose was repeated, based on pain score assessment, at a minimum interval of 2-4 hours. Also, both groups received midazolam bolus at a dose of 0.1 mg/ kg/dose IV as adjuvant sedative in both groups when the patient was agitated.
    Need of skeletal muscle relaxant
    Neonates in both groups received Pancuronium at a dose of 0.1 mg/ kg /dose IV as a skeletal muscle relaxant when two boluses of midazolam failed to control agitation
    Time to extubation.
    Days upon mechanical ventilation
    Time to reach 100ml/kg/day enteral feed.
    Days to reach 100ml/kg/day enteral feed.
    Length of hospital stay.
    Days of hospital admission
    Mortality
    Death
    Adverse effects of the sedative drugs
    Hypotension, bradycardia, chest wall rigidity, feeding intolerance withdrawal signs,re-intubation within 48 hours
    Culture-proven sepsis

    Full Information

    First Posted
    April 5, 2022
    Last Updated
    April 5, 2022
    Sponsor
    Mansoura University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05324891
    Brief Title
    Dexmedetomidine Versus Fentanyl for Sedation of Postoperative Mechanically Ventilated Neonates
    Official Title
    Dexmedetomidine Versus Fentanyl for Sedation of Postoperative Mechanically Ventilated Neonates
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2022
    Overall Recruitment Status
    Completed
    Study Start Date
    January 2016 (Actual)
    Primary Completion Date
    August 2017 (Actual)
    Study Completion Date
    August 30, 2017 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Mansoura University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    Yes
    Studies a U.S. FDA-regulated Device Product
    No
    Product Manufactured in and Exported from the U.S.
    Yes
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Newborn infants experience pain after surgical procedures,prevention and management of pain in neonates is important due to its deleterious consequences. Fentanyl is a widely used analgesic which promotes rapid analgesia,however, is not free of adverse effects including chest wall rigidity, hypothermia, hypotension, respiratory depression and tolerance.Dexmedetomidine is a selective α 2-adrenergic agonist can cause sedation, anxiolysis, analgesia and minimal respiratory depression.Therefore, the objective of the study is to evaluate the safety and efficacy of dexmedetomidine compared to fentanyl in postoperative mechanically ventilated neonates.
    Detailed Description
    A prospective, randomized trial, which was conducted upon neonates who needed postoperative mechanical ventilation in Neonatal Intensive Care Unit, Mansoura University Children's Hospital.The patients were randomized to two groups according to the drug they received for postoperative sedation. The first group received dexmedetomidine infusion and the second group received fentanyl infusion.Our primary outcome was the efficacy of postoperative sedation score, and the secondary outcomes were plasma cortisol level, time to extubation, time to reach 100ml/kg enteral feed, need for adjuvant sedative and skeletal muscle relaxant, length of the hospital stay, side effects of sedative drugs and mortality.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Postoperative Pain

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 2
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantCare ProviderInvestigatorOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    40 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Fentanyl
    Arm Type
    Active Comparator
    Arm Description
    Neonates received fentanyl infusion during postoperative phase.
    Arm Title
    Dexmedetomidine
    Arm Type
    Active Comparator
    Arm Description
    Neonates received dexmedetomidine infusion during postoperative phase.
    Intervention Type
    Drug
    Intervention Name(s)
    Dexmedetomidine
    Intervention Description
    Infants received dexmedetomidine IV loading dose: 0.5 mcg/kg given over 20 minutes followed by maintenance dose 0.3 µg/kg/hour by infusion over 24 hours.Weaning was done when the patient was about to be extubated or with maximum 5 days after the randomization.
    Intervention Type
    Drug
    Intervention Name(s)
    Fentanyl
    Intervention Description
    Infants received Fentanyl IV continuous infusion: 1µg/ kg /hour. Weaning was done when the patient was about to be extubated or with maximum 5 days after the randomization.
    Primary Outcome Measure Information:
    Title
    The efficacy of postoperative sedation according to pain score.
    Description
    Assessment of Neonatal Pain, Agitation and Sedation Scale immediately after the operations then every 12 hours till 5 days
    Time Frame
    upto five days after surgical intervention
    Secondary Outcome Measure Information:
    Title
    Plasma cortisol level
    Description
    Plasma as a base line after the operation and another two measures one after 24 hours from the operation and the other after 48 hours
    Time Frame
    Within 48 hours after surgical intervention
    Title
    Need of adjuvant analgesics or sedatives
    Description
    Infants in both groups received open-label intravenous fentanyl boluses at a dose of 1µg/kg, as adjuvant analgesic when the pain score was more than 3 points. The dose was repeated, based on pain score assessment, at a minimum interval of 2-4 hours. Also, both groups received midazolam bolus at a dose of 0.1 mg/ kg/dose IV as adjuvant sedative in both groups when the patient was agitated.
    Time Frame
    upto five days after surgical intervention
    Title
    Need of skeletal muscle relaxant
    Description
    Neonates in both groups received Pancuronium at a dose of 0.1 mg/ kg /dose IV as a skeletal muscle relaxant when two boluses of midazolam failed to control agitation
    Time Frame
    upto five days after surgical intervention
    Title
    Time to extubation.
    Description
    Days upon mechanical ventilation
    Time Frame
    upto 21 days postoperative
    Title
    Time to reach 100ml/kg/day enteral feed.
    Description
    Days to reach 100ml/kg/day enteral feed.
    Time Frame
    upto 21 days postoperative
    Title
    Length of hospital stay.
    Description
    Days of hospital admission
    Time Frame
    upto 30 days postoperative
    Title
    Mortality
    Description
    Death
    Time Frame
    upto 21 days postoperative
    Title
    Adverse effects of the sedative drugs
    Description
    Hypotension, bradycardia, chest wall rigidity, feeding intolerance withdrawal signs,re-intubation within 48 hours
    Time Frame
    upto seven days after surgical intervention
    Title
    Culture-proven sepsis
    Time Frame
    upto 30 days after surgical intervention

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    1 Hour
    Maximum Age & Unit of Time
    4 Weeks
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Neonates need postoperative ventilation. Exclusion Criteria: Major congenital cardiovascular anomalies. Chromosomal anomalies. Grade IV intraventricular hemorrhage. Tracheoesophageal fistula with wide gap (distance between proximal and distal end more than two centimeters).

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Dexmedetomidine Versus Fentanyl for Sedation of Postoperative Mechanically Ventilated Neonates

    We'll reach out to this number within 24 hrs